Abstract: Percutaneous left atrial appendage (LAA) exclusion is an evolving treatment to prevent embolic events in patients with non-valvular atrial fibrillation, especially in patients who have contraindications to warfarin therapy. This paper reviews the indications, clinical trials, limitations and progress of left atrial appendage occlusion.